Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today novel data and filing of a patent application describing a unique mechanism of action of its JadiCell™ universal donor stem cell.
JadiCell™ was shown to significantly improve survival in COVID-19 patients with Acute Respiratory Distress Syndrome (ARDS) and also reduce lung scarring associated with long-COVID-19.